October 2015

Researchers have found that presence of a protein in blood can be an early indicator of end-stage renal disease -- and ultimately of death -- in people with hypertension.

By tracking a single cell in a growing heart, Stanford University scientists have discovered a cell type that could repair damaged arteries.

British researchers said they have identified a new gene linked to nerve function, that could hold the key to treating neurodegenerative diseases such as Parkinson's disease.

Three days after Nestle India announced 100 percent safety clearance of Maggi noodle samples, the Gujarat government on Monday announced lifting of the ban on selling the popular food item, a top official said.

The Karnataka government on Monday lifted ban on the sale of Maggi noodles across the state with immediate effect, Health Minister U.T.Khader said.

Taiwan has become the world's fastest ageing country this decade, overtaking Japan, the US, Britain and other developed nations, according to a report published on Monday by the National Development Council (NDC).

Stryker Corporation, one of the world's leading medical technology companies instruments division of interventional spine business unit has received clearance from the US Food and Drug Administration (FDA) to market its expanded indications of VertaPlex HV for the treatment of sacral insufficiency fractures.

Regular physical activity tends to be a burden for women with diabetes than non-diabetic women, which in turn threatens to make them more sedentary and cause their health to worsen, revealed a new study. The study was published in the Journal BMJ Open Diabetes Research and Care.

A senior Indian scientist has claimed that the malaria cure artemisinin, whose discovery fetched a Chinese scientist the Nobel prize in medicine this year, has roots in India.

U.S. health regulators approved Praxbind, a reversal agent made by Germany Private held Boehringer Ingelheim, for use in emergency situations by patients taking the company's widely used Pradaxa blood thinner. Praxbind, an intravenous injection, is the first reversal agent approved specifically for Pradaxa and works by binding to the drug compound to neutralize it.